Rheumatology Network's Top 5: July 9, 2022

Published on: 

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending July 9, 2022.

Early Methotrexate Can Alter Disease Course in Those At-Risk of Rheumatoid Arthritis

Use of methotrexate in the prearthritis stage of joint symptoms and subclinical inflammation could alter the disease course of clinical arthritis.

David Felson, MD, MPH: Assessing Disease Activity in Patients with RA and Low Joint Count

David Felson, MD, MPH, discusses his recent study, “Meaning of patient global assessment when joint counts are low in rheumatoid arthritis.”

Is There a Link Between Maternal Infection and Juvenile Idiopathic Arthritis?

Previous attempts to make associations between JIA and prenatal maternal infection is difficult due to the rarity of JIA diagnosis and recall bias.

Rheumatoid Arthritis Quiz: Activity Trackers and RA

Many people now use activity trackers to assess their activity levels, but what role can these devices play in managing rheumatoid arthritis patients? Test your knowledge with this quiz.

FDA Approves Pegloticase Injection Plus Methotrexate for Patients with Uncontrolled Gout

The decision was based on results from the MIRROR trial, which evaluated the concomitant use of pegloticase with methotrexate.